Waldron Private Wealth LLC Makes New $54,000 Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Waldron Private Wealth LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, Holdings Channel reports. The fund acquired 550 shares of the exchange traded fund’s stock, valued at approximately $54,000.

Other large investors also recently modified their holdings of the company. Leo Wealth LLC raised its holdings in SPDR S&P Biotech ETF by 30.6% during the third quarter. Leo Wealth LLC now owns 4,281 shares of the exchange traded fund’s stock valued at $423,000 after acquiring an additional 1,002 shares during the period. Sequoia Financial Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 74.7% during the third quarter. Sequoia Financial Advisors LLC now owns 4,002 shares of the exchange traded fund’s stock worth $395,000 after purchasing an additional 1,711 shares in the last quarter. Oakworth Capital Inc. raised its stake in SPDR S&P Biotech ETF by 4.2% during the 3rd quarter. Oakworth Capital Inc. now owns 5,963 shares of the exchange traded fund’s stock valued at $589,000 after purchasing an additional 242 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its holdings in SPDR S&P Biotech ETF by 2.6% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 153,631 shares of the exchange traded fund’s stock worth $15,178,000 after purchasing an additional 3,912 shares in the last quarter. Finally, Whittier Trust Co. boosted its stake in SPDR S&P Biotech ETF by 3.3% in the 3rd quarter. Whittier Trust Co. now owns 311,027 shares of the exchange traded fund’s stock worth $30,729,000 after purchasing an additional 9,976 shares during the period.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $96.67 on Thursday. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The firm’s 50 day moving average price is $99.16 and its 200-day moving average price is $94.52. The stock has a market cap of $7.37 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.